Expression of heat-shock proteins hsp27, hsp70 and hsp90 in malignant epithelial tumour of the ovaries

APMIS

Volumn 111, Issue 4, 2003, Pages 523-530

  Elpek, Gülsüm Özlem ^a   Karaveli, Şeyda ^a   Şimşek, Tayyup ^a   Keleş, Nuran ^a   Aksoy, Nazif Hikmet ^a  

^a AKDENIZ UNIVERSITY   (Turkey)

Author keywords

hsp27; hsp70; hsp90; Ovarian carcinoma

Indexed keywords

HEAT SHOCK PROTEIN; HEAT SHOCK PROTEIN 27; HEAT SHOCK PROTEIN 70; HEAT SHOCK PROTEIN 90;

ADULT; AGED; ARTICLE; ASCITES; CANCER SURVIVAL; CHI SQUARE DISTRIBUTION; CONTROLLED STUDY; DISEASE MARKER; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; OVARY CARCINOMA; PATHOGENESIS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; REGRESSION ANALYSIS; STATISTICAL ANALYSIS; SURVIVAL RATE; TREATMENT OUTCOME;

ADULT; AGED; FEMALE; HEAT-SHOCK PROTEINS; HSP70 HEAT-SHOCK PROTEINS; HSP90 HEAT-SHOCK PROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; NEOPLASM PROTEINS; NEOPLASM STAGING; OVARIAN NEOPLASMS; PROPORTIONAL HAZARDS MODELS;

EID: 0038377853     PISSN: 09034641     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0463.2003.1110411.x     Document Type: Article

References (31)

1. Lindquist S, Craig EA. The heat-shock proteins. Annu Rev Genet 1988;22:631-77.
2. Buchner J. Supervising the fold: functional principles of molecular chaperons. FASEB J 1996;10: 10-9.
3. Benjamin IJ, Horie S, Greenberg ML, Alpern R J, Williams RS. Induction of stress proteins in cultured myogenic cells. Molecular signals for the activation of heat shock transcription factor during ischemia. J Clin Invest 1992;89:1685-9.
4. Kochevar DT, Aucoin MM, Cooper J. Mammalian heat shock proteins: an overview with a systems perspective. Toxicol Lett 1991;56:243-67.
5. Burdon RH. Heat shock proteins in relation to medicine. Mol Aspects Med 1993;11:83-165.
6. Richards EH, Hickey E, Weber L, Master JR. Effect of overexpression of the small heat shock protein Hsp27 on the heat and drug sensitivities of human testis tumour cells. Cancer Res 1996; 56:2446-51.
7. Oesterreich S, Weng CN, Qiu M, Hilsenbeck SG, Osborne CK, Fuqua SA. The small heat-shock protein hsp27 correlated with growth and drug resistance in human breast-cancer cell lines. Cancer Res 1993;53:4443-8.
8. Garrido C, Mehlen P, Fromentin A, Hammann A, Assem M, Arrigo AP, et al. Inconstant association between 27-kDa heat-shock protein (Hsp27) content and doxorubicin resistance in human colon cancer cells. The doxorubicin-protecting effect of Hsp27. Eur J Biochem 1996;237: 653-9.
9. Conroy SE, Sasieni PD, Fentiman I, Latchman DS. Autoantibodies to the 90kDa heat shock protein and poor survival in breast cancer patients. Eur J Cancer 1998;34:942-3.
10. Luo LY, Herrera I, Soosaipillai A, Diamandis EP. Identification of heat shock protein 90 and other proteins as tumour antigens by serological screening of an ovarian carcinoma expression library. Br J Cancer 2002 29;87:339-43.
11. Hu W, Wu W, Yeung SC, Freedman RS, Kavanagh JJ, Verschraegen CF. Increased expression of heat shock protein 70 in adherent ovarian cancer and mesothelioma following treatment with manumycin, a farnesyl transferase inhibitor. Anticancer Res 2002;22:665-72.
12. Vargas-Roig LM, Gago FE, Tello O, Aznar JC, Ciocca DR. Heat shock protein expression and drug resistance in breast cancer patients treated with induction chemotherapy. Int J Cancer 1998 23;79:468-75.
13. Kapranos N, Kominea A, Konstantinopoulos PA, Savva S, Artelaris S, Vandoros G, Sotiropoulou-Bonikou G, et al. Expression of the 27-kDa heat shock protein (HSP27) in gastric carcinomas and adjacent normal, metaplastic, and dysplastic gastric mucosa, and its prognostic significance. J Cancer Res Clin Oncol 2002;128:426-32.
14. Mese H, Sasaki A, Nakayama S, Yoshioka N, Yoshihama Y, Kishimoto K, Matsumura T. Prognostic significance of heat shock protein 27 (HSP27) in patients with oral squamous cell carcinoma. Oncol Rep 2002;9:341-4.
15. Cornford PA, Dodson AR, Parsons KF, Desmond AD, Woolfenden A, Fordham M, et al. Heat shock protein expression independently predicts clinical outcome in prostate cancer. Cancer Res 2000;60:7099-105.
16. Noguchi T, Takeno S, Shibata T, Uchida Y, Yokoyama S, Muller W. Expression of heat shock protein 70 in grossly resected esophageal squamous cell carcinoma. Ann Thorac Surg 2002;74: 222-6.
17. Ricaniadis N, Kataki A, Agnantis N, Androulakis G, Karakousis CP. Long-term prognostic significance of HSP-70, c-myc and HLA-DR expression in patients with malignant melanoma. Eur J Surg Oncol 2001;27:88-93.
18. Nanbu K, Konishi I, Komatsu T, Mandai M, Yamamoto S, Kuroda H, et al. Expression of heat shock proteins Hsp70 and Hsp90 in endometrial carcinomas. Correlation with clinicopathology, sex steroid receptor status, and p53 protein expression. Cancer 1996;77:330-8.
19. Nanbu K, Konishi I, Mandai M, Kuroda H, Hamid AA, Komatsu T, et al. Prognostic significance of heat shock proteins HSP70 and HsP90 in endometrial carcinomas. Cancer Detect Prev 1998;22:549-55.
20. Langdon SR Rabiasz GJ, Hirst GL, King RJ, Hawkins RA, Smyth JF, et al. Expression of the heat shock protein hsp27 in human ovarian cancer. Clin Cancer Res 1995;1:1603-9.
21. Arts HJ, Hollema H, Lemstra W, Willemse PH, De Vries EG, Kampinga HH, et al. Heat-shock-protein-27 (hsp27) expression in ovarian carcinoma: relation in response to chemotherapy and prognosis. Int J Cancer 1999;84:234-8.
22. Geisler JP, Geisler HE, Tammela J, Wiemann MC, Zhou Z, Miller GA, et al. Heat shock protein 27: an independent prognostic indicator of survival in patients with epithelial ovarian carcinoma. Gynecol Oncol 1998;69:14-6.
23. Germain I, Tetu B, Brisson J, Mondor M, Cherian MG. Markers of chemoresistance in ovarian carcinomas: an immunohistochemical study of 86 cases. Int J Gynecol Pathol 1996;15:54-62.
24. International Federation of Gynaecology and Obstetrics. Changes in definitions of clinical staging for cancer of the cervix and ovary. Am J Obstet Gynecol 1987,236-41.
25. Czernobilsky B. Common epithelial tumour of the ovary. In: Kurman RJ, editor. Blaustein's Pathology of the Female Genital Tract. New York: Springer-Verlag, 1987:560-607.
26. Sobre B, Frankendal BO, Verres B. Importance of histologic grading in the prognosis of epithelial ovarian carcinoma. Obstet Gynecol 1982; 59:576-82.
27. Maehara Y, Oki E, Abe T, Tokunaga E, Shibahara K, Kakeji Y, et al. Overexpression of the heat shock protein HSP70 family and p53 protein and prognosis for patients with gastric cancer. Oncology 2000;58:144-51.
28. Mileo AM, Fanuele M, Battaglia F, Scambia G, Benedetti-Panici P, Mancuso S, et al. Selective over-expression of mRNA coding for 90 KDa stress-protein in human ovarian cancer. Anticancer Res 1990;10:903-6.
29. Koshiyama M, Konishi I, Mandai M, Komatsu T, Yamamoto S, Nanbu K, et al. Immunohistochemical analysis of p53 protein and 72 kDa heat shock protein (HSP72) expression in ovarian carcinomas. Correlation with clinicopathology and sex steroid receptor status. Virchows Arch 1995; 425:603-9.
30. Volm M, Koomagi R, Kaufmann M, Mattern J, Stammler G. Microvessel density, expression of proto-oncogenes, resistance-related proteins and incidence of metastases in primary ovarian carcinomas. Clin Exp Metastasis 1996;14:209-14.
31. Parker SL, Tong T, Bolden S, Wingo PA. Cancer statistics. CA Cancer J Clin 1997;47:5-27.